drugset / Trial / NCT00717054
Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to compare the incidence of nausea, vomiting, need for rescue medication, prolonged PACU time, and unplanned hospital admission in patients with high risk for post-operative nausea and vomiting (PONV) treated with oral aprepitant with or without transdermal scopolamine preoperatively.
Timeline
- Start
- 2008-02
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Scopolamine | Unknown | — | Other |
| Comparator | Aprepitant | Other / unclassified | 40 mg | Oral |
Indications
No indication recorded.